Literature DB >> 2898864

New selective dopamine D-2 antagonists as antipsychotic agents. Pharmacological, chemical, structural and theoretical considerations.

T Högberg, S Rämsby, S O Ogren, U Norinder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2898864

Source DB:  PubMed          Journal:  Acta Pharm Suec        ISSN： 0001-6675


× No keyword cloud information.
  7 in total

1.  Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats.

Authors:  D C Hoffman
Journal:  J Neural Transm Gen Sect       Date:  1992

Review 2.  A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride.

Authors:  Jennifer L Martelle; Michael A Nader
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

3.  A multiway 3D QSAR analysis of a series of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxybenzamides.

Authors:  J Nilsson; E J Homan; A K Smilde; C J Grol; H Wikström
Journal:  J Comput Aided Mol Des       Date:  1998-01       Impact factor: 3.686

4.  NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors.

Authors:  H Hall; T Högberg; C Halldin; C Köhler; P Ström; S B Ross; S A Larsson; L Farde
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  D1 and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia.

Authors:  D C Hoffman; H Donovan
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

6.  Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system.

Authors:  J L Andersson; M Marcus; G G Nomikos; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

7.  Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.

Authors:  J L Andersson; G G Nomikos; M Marcus; P Hertel; J M Mathé; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.